Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
BELLICUM PHARMACEUTICALS, INC | Chief Development Officer | Stock Option (right to buy) | 250K | Aug 15, 2022 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
BLCM | BELLICUM PHARMACEUTICALS, INC | Aug 15, 2022 | 1 | $360K | 4 | Aug 16, 2022 | Chief Development Officer |
BLCM | BELLICUM PHARMACEUTICALS, INC | Dec 1, 2021 | 1 | $260K | 4 | Dec 2, 2021 | Chief Development Officer |
BLCM | BELLICUM PHARMACEUTICALS, INC | Dec 1, 2021 | 0 | $0 | 3 | Dec 2, 2021 | Chief Development Officer |